Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount  |
|---|---|---|---|---|---|---|
| EMD Millipore Corp. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2017 | EPA | $385,000 |
| EMD MILLIPORE CORPORATION | Merck KGaA (EMD) | pharmaceuticals | water pollution violation | 2017 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $385,000 |
| Pharmacia Corp. | Pfizer | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $400,000 |
| Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $400,000 |
| Dr. Reddy's Laboratories Ltd. | Dr. Reddy's Laboratories | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $400,000 |
| Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $400,000 |
| Neutrogena Corp. | Johnson & Johnson | pharmaceuticals | environmental violation | 2014 | CA-DTSC | $416,248 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2006 | GA-AG | $418,952 |
| MALLINCKRODT, LLC | Mallinckrodt | pharmaceuticals | hazardous waste violation | 2013 | EPA | $449,740 |
| ABBOTT LABS - N. CHICAGO PLANT | AbbVie | pharmaceuticals | air pollution violation | 2006 | EPA | $475,672 |
| Phibro-Tech Inc. | Phibro Animal Health | pharmaceuticals | environmental violation | 2019 | CA-DTSC | $495,000 |
| McNeil-PPC Inc. | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2015 | AL-AG | $500,000 |
| Par Pharmaceutical, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $500,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2015 | CA-MULTI | $506,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | Controlled Substances Act violation | 2008 | USAO | $511,000 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | AR-AG | $525,780 |
| MILLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2010 | EPA | $526,500 |
| CSL Behring, LLC | CSL Limited | pharmaceuticals | air pollution violation | 2021 | EPA | $527,144 |
| CSL BEHRING LLC | CSL Limited | pharmaceuticals | air pollution violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
| Hoffmann-La Roche, Inc. | Roche | pharmaceuticals | employment discrimination | 2012 | private lawsuit-federal | $545,833 |
| AstraZeneca | AstraZeneca | pharmaceuticals | employment discrimination | 2021 | OFCCP | $560,000 |
| Alpharma USPD, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $600,000 |
| Dey, Inc. | Viatris | pharmaceuticals | fraud | 2004 | AR-AG | $600,000 |
| Purepac Pharmaceutical Co. | Pfizer | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $600,000 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | kickbacks and bribery | 2006 | KY-AG | $600,000 |
| Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | pharmaceuticals | environmental violation | 2021 | MA-AG | $600,000 |
| Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $625,000 |
| Lupin Ltd. | Lupin Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $625,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
| Synthes Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
| Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | NV-AG | $670,000 |
| Pharmacia & Upjohn Company | Pfizer | pharmaceuticals | air pollution violation | 2005 | EPA | $676,250 |
| Pfizer Inc. | Pfizer | pharmaceuticals | consumer protection violation | 2018 | NY-AG | $700,000 |
| Pfizer Pharmaceuticals LLC | Pfizer | pharmaceuticals | air pollution violation | 2014 | EPA | $728,000 |
| Pfizer Pharmaceuticals, LLC | Pfizer | pharmaceuticals | air pollution violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $728,000 |
| Alpharma, Inc. | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
| Lupin Pharmaceuticals | Lupin Limited | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $750,000 |
| Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | False Claims Act and related | 2013 | ID-AG | $750,000 |
| Perrigo Company | Perrigo | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
| Warrick Pharmaceuticals Corp. and Schering-Plough Corp. | Merck | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $750,000 |
| Endo Pharmaceuticals | Endo International | pharmaceuticals | consumer protection violation | 2019 | CA-AG | $760,000 |
| Forest Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $790,000 |
| TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | kickbacks and bribery | 2006 | WI-AG | $798,000 |
| Pernix Therapeutics | Currax Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $800,000 |
| Allergan | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $806,991 |
| AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2004 | FL-AG | $807,826 |
| American BioScience Inc. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $815,000 |
| Knoll Pharmaceuticals | AbbVie | pharmaceuticals | consumer protection violation | 2001 | AR-AG | $826,957 |
| Sanofi-Aventis U.S. LLC | Sanofi | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $828,500 |
| Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2004 | WV-AG | $850,000 |
| BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $900,000 |
| Allergan | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $934,903 |
| Pfizer Inc. | Pfizer | pharmaceuticals | air pollution violation | 2008 | EPA | $975,000 |
| Pfizer | Pfizer | pharmaceuticals | consumer protection violation | 2019 | OR-AG | $975,000 |
| PFIZER GLOBAL MANUFACTURING | Pfizer | pharmaceuticals | air pollution violation | 2008 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $975,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
| Schering-Plough Corporation | Merck | pharmaceuticals | investor protection violation | 2003 | SEC | $1,000,000 |
| ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2002 | SEC | $1,000,000 |
| Abbott Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | ID-AG | $1,000,000 |
| Eisai | Eisai | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,000,000 |
| General Nutrition Corp. | Harbin Pharmaceutical Group | pharmaceuticals | consumer protection violation | 2002 | FL-AG | $1,000,000 |
| Lupin Pharmaceuticals Inc. | Lupin Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $1,000,000 |
| Allergan | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $1,003,634 |
| Purdue Frederick Company, Inc. and Purdue Pharma, L.P. | Purdue Pharma | pharmaceuticals | Controlled Substances Act violation | 2007 | NV-AG | $1,047,787 |
| Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2006 | ID-AG | $1,072,700 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
| Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,100,000 |
| Astellas | Astellas Pharma | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,130,000 |
| Lupin Ltd. | Lupin Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $1,143,750 |
| Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
| Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $1,340,000 |
| Boehringer Ingleheim | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
| SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
| Merck | Merck | pharmaceuticals | environmental violation | 2011 | EPA | $1,500,000 |
| MERCK & CO., INC. | Merck | pharmaceuticals | air pollution violation | 2011 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,500,000 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | consumer protection violation | 2019 | WV-AG | $1,600,000 |
| Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $1,600,000 |
| Purdue Frederick Co. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2008 | TX-AG | $1,600,000 |
| Sanofi-Aventis | Sanofi | pharmaceuticals | consumer protection violation | 2019 | WV-AG | $1,600,000 |
| Aventis Pharmaceuticals, Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
| Eli Lilly | Eli Lilly | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $1,650,000 |
| Par Pharmaceutical Cos., Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
| Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
| Novo Nordisk Inc. | Novo Holdings A/S | pharmaceuticals | False Claims Act and related | 2011 | USAO | $1,725,000 |
| Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $1,750,000 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $1,750,000 |
| Sigma Aldrich Research Biochemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | export control violation | 2002 | BIS | $1,760,000 |
| AbbVie Inc. | AbbVie | pharmaceuticals | kickbacks and bribery | 2018 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,800,000 |
| Anda | Teva Pharmaceutical Industries | pharmaceuticals | Controlled Substances Act violation | 2016 | WV-AG | $1,800,000 |
| Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
| Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
| Shire LLC | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,850,000 |
| Valeant Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | insurance violation | 2018 | CA-INS | $1,875,000 |
| Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
| General Nutrition | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2007 | private lawsuit-federal | $1,910,000 |
